Metraipolis › archive › dc_6f3fac0932b2

A Potent Oral Sialylation Inhibitor Augments the Immunotherapy in Pancreatic Ductal Adenocarcinoma — Europe PMC PMID:41142343

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41142343
DOI
10.1021/acscentsci.5c00939
License (as archived)
solo-consultazione
Archived
2026-11-10T04:01:21.047Z
SHA-256 of the archived text
b489d4066931fbb81e90e743341150b382b45c2c492c2d7908a779eb381e4951
Stable URL of this page
https://metraipolis.com/documento/dc_6f3fac0932b2

How to cite

A Potent Oral Sialylation Inhibitor Augments the Immunotherapy in Pancreatic Ductal Adenocarcinoma — Europe PMC PMID:41142343 — Europe PMC (en), https://europepmc.org/article/MED/41142343 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6f3fac0932b2 (Metraipolis archive dc_6f3fac0932b2, sha256 b489d4066931fbb81e90e743341150b382b45c2c492c2d7908a779eb381e4951)
BibTeX
@misc{dc6f3fac0932b2,
  title = {A Potent Oral Sialylation Inhibitor Augments the Immunotherapy in Pancreatic Ductal Adenocarcinoma — Europe PMC PMID:41142343},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41142343},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6f3fac0932b2; sha256 b489d4066931fbb81e90e743341150b382b45c2c492c2d7908a779eb381e4951},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41142343. Agents can read the archived copy with the MCP tool read_document.